If it has not produced a vaccine, Switzerland is very active on anti-Covid treatments.
While vaccines are developing rapidly to fight against Covid, Swiss companies and pharmaceutical giants are very present to develop alternatives. For the moment, they are four in number.
First, there is that of Bâlois Roche, in collaboration with the American Regeneron. This medicine consists of a combination of antibodies. The laboratory claimed in the spring that his treatment was “the only combination of monoclonal antibodies, which retains its potency against the great new variants that are emergingThe first doses of RegN-Cov2 were distributed, after validation by Swiss Medic and the Federal Office of Public Health, a few weeks ago.
Read the entire article in the paper version of La Voix de l’Ain (Haut-Bugey edition), available on newsstands until Thursday, July 8, or by accessing The online store.
–
